Changes in expressions of ADAM9, 10, and 17 as well as α-secretase activity in renal cell carcinoma

The loss of α-secretase activity observed here in conjunction with previous findings argue against tumorigenic effects of ADAM9, 10, and 17 supporting that increased nuclear and cytoplasmic expression may be an attempt to compensate for loss of function.